Literature DB >> 7966741

Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli.

J Ena1, C Amador, C Martinez, V Ortiz de la Tabla.   

Abstract

From January 1990 to December 1992, ciprofloxacin resistant Escherichia coli was isolated in 125 of 1,946 urine cultures (6.4%) with more than 10(5) colony-forming units per ml. To determine the risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant E. coli a retrospective chart review was done. Data from 54 patients with urinary tract infections caused by ciprofloxacin resistant E. coli were compared with 51 controls matched by temporal occurrence and randomly selected among 540 patients with urinary tract infections caused by ciprofloxacin susceptible E. coli. Patients had greater proportions of asymptomatic bacteriuria or lower urinary tract symptoms (85% versus 61%, p = 0.01) and of relapse (22% versus 0%, p = 0.001) than controls. Urinary tract abnormalities (odds ratio 7.98, 95% confidence interval 2.7 to 3.1, p < 0.001), patient age 65 years or older (odds ratio 6.48, 95% confidence interval 2.2 to 19.1, p < 0.001), previous treatment with quinolones (odds ratio 19.09, 95% confidence interval 2.2 to 166.5, p = 0.008) and urinary catheterization (odds ratio 2.92, 95% confidence interval 1.1 to 8.5, p = 0.048) were independently associated with infections caused by ciprofloxacin resistant strains. Our results suggest that patients with urological abnormalities previously treated with quinolones are especially prone to urinary tract infection caused by ciprofloxacin resistant strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7966741     DOI: 10.1097/00005392-199501000-00040

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Wagging the dog: antibiotic use and the emergence of resistance.

Authors:  E Lautenbach; N O Fishman
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.

Authors:  A Sotto; C M De Boever ; P Fabbro-Peray; A Gouby; D Sirot; J Jourdan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Bacterial sepsis following prostatic biopsy.

Authors:  Luca Carmignani; Stefano Picozzi; Matteo Spinelli; Salvatore Di Pierro; Gabriella Mombelli; Ercole Negri; Milvana Tejada; Paola Gaia; Elena Costa; Augusto Maggioni
Journal:  Int Urol Nephrol       Date:  2012-02-28       Impact factor: 2.370

4.  Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Authors:  J Garau; M Xercavins; M Rodríguez-Carballeira; J R Gómez-Vera; I Coll; D Vidal; T Llovet; A Ruíz-Bremón
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.

Authors:  S W Wright; K D Wrenn; M L Haynes
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

6.  Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota.

Authors:  Burcu Tepekule; Pia Abel Zur Wiesch; Roger D Kouyos; Sebastian Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-30       Impact factor: 11.205

7.  Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine.

Authors:  T A Russo; U B Carlino; A Mong; S T Jodush
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.

Authors:  L C McDonald; F J Chen; H J Lo; H C Yin; P L Lu; C H Huang; P Chen; T L Lauderdale; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.

Authors:  Guillermo Martín-Gutiérrez; Jerónimo Rodríguez-Beltrán; José Manuel Rodríguez-Martínez; Coloma Costas; Javier Aznar; Álvaro Pascual; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Incidence and risk factors for nosocomial infections caused by fluoroquinolone-resistant Escherichia coli.

Authors:  K Huotari; E Tarkka; V Valtonen; E Kolho
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-18       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.